Leinco Technologies

Anti-Human CDw60 (9-0-acetyl GD3) - FITC

Product Code:
 
LEI-C293
Product Group:
 
Primary Antibodies
Host Type:
 
Mouse
Antibody Isotype:
 
IgM
Antibody Clonality:
 
Monoclonal
Antibody Clone:
 
Jones
Regulatory Status:
 
RUO
Target Species:
 
Human
Application:
 
Flow Cytometry
Shipping:
 
Ambient
Storage:
 
This Fluorescein conjugate is stable when stored at 2-8°C. Do not freeze.
 

No additional charges, what you see is what you pay! *

CodeSizePrice
LEI-C293-50ug50 ug£152.00
Quantity:
LEI-C293-100ug100 ug£209.00
Quantity:
LEI-C293-200ug200 ug£303.00
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: US.
Typical lead time: 14-21 working days.
Contact us for more accurate information.
  • Further Information
  • References
  • Show All

Further Information

Antigen Distribution:
The CDw60 antigen is present on gangliosides, platelets and a subset of CD4+, CD8+ peripheral T-cells, but not on B-cells, monocytes or granulocytes. CDw60 is involved in the co-stimulation of T-cells. The antigen is also detectable in some previously undescribed benign and malignant tumors. CDw60 shows different subcellular distribution patterns.
Concentration:
0.2 mg/ml
Conjugate/Tag/Label:
Fluorescein (FITC)
Format:
This Fluorescein (FITC) conjugate is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative.
Formulation:
This Fluorescein (FITC) conjugate is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative.
Target:
CDw60

References

1. Leukocyte Typing V (1995) Oxford University Press 2. Blum, A. S. and Barnstable, C. J. et al. (1987) Proc. Natl. Acad. Sci. 84:8716 3. Constantine-Paton, M. et al. (1986) Nature 324:659